All In Biotech

Free tool

FAERS Monitor: Qudexy Xr

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205122 or its brand name (Qudexy Xr, Topiramate). Reports on generic versions are filed under their own applications.

Reports

50,790

Serious

38,762

76% of reports

Hospitalization

14,435

Death reported

5,657

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective7,062
  • off label use5,701
  • headache3,701
  • nausea3,349
  • fatigue3,211
  • product use in unapproved indication2,627
  • pain2,577
  • migraine2,555
  • dizziness2,442
  • seizure2,293
  • diarrhoea2,219
  • condition aggravated2,216
  • vomiting2,196
  • drug intolerance2,143
  • depression1,977

Reports by year received

View as table
YearReports
2004139
2005254
2006207
2007196
2008383
2009775
2010941
20111,213
20121,395
20131,214
20141,551
20152,440
20162,976
20172,710
20183,587
20193,999
20203,696
20213,734
20223,599
20233,912
20244,566
20254,472
20262,826

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,003,369 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
migraineSignal2,55511.410.923,593
drug intoleranceSignal2,1439.49.015,736
seizureSignal2,2938.48.014,652
product use in unapproved indicationSignal2,6274.44.36,971
depressionSignal1,9773.63.53,756
condition aggravatedSignal2,2163.02.93,040
off label useSignal5,7012.72.66,361
headacheSignal3,7012.52.43,263
drug ineffectiveSignal7,0622.22.25,056
dizzinessSignal2,4422.02.01,305
vomiting2,1961.91.91,015
nausea3,3491.81.71,126
pain2,5771.71.7832
fatigue3,2111.71.7980
diarrhoea2,2191.41.4289

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.